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Class switch recombination (CSR) is a DNA recombi-
nation reaction that diversifies the effector functions
of antibodies. CSR occurs via the formation and non-
homologous end joining (NHEJ) repair of pro-
grammed DNA double-strand breaks (DSBs) at the
immunoglobulin heavy chain locus. The DNA repair
factors 53BP1 and Rif1 promote NHEJ and CSR by
protecting DSBs against resection. However, to
what extent repression of DNA end resection contrib-
utes to CSR is unknown. Here, we show that B lym-
phocytes devoid of 53BP1-Rif1-dependent DSB
end protection activity undergo robust CSR. Inacti-
vation of specific sets of phospho-sites within
53BP1 N-terminal SQ/TQ motifs abrogates Rif1
recruitment and inhibition of resection but only mildly
reduces CSR. Furthermore, mutations within 53BP1
oligomerization domain abolish CSR without sub-
stantially affecting DNA end processing. Thus, inhibi-
tion of DNA end resection does not correlate with
CSR efficiency, indicating that regulation of DSB pro-
cessing is not a key determinant step in CSR.
INTRODUCTION
The diversity of human immunoglobulin (Ig) gene repertoire is
shaped by antibody diversification processes occurring at
different stages of B lymphocytes development (Dudley et al.,
2005; Methot and Di Noia, 2017). Class switch recombination
(CSR) is a DNA rearrangement reaction occurring in mature B
lymphocytes, which replaces the constant portion of the IgM
heavy chain with one of the alternative isotypes (IgG, IgA, or
IgE). As a consequence, this process alters the Ig effector func-
tion without affecting its antigen specificity (Chaudhuri and Alt,
2004; Methot and Di Noia, 2017). CSR is crucial to the establish-
ment of a proper immune response because it enhances the
capability of antigen-specific Igs to effectively dispose of the
pathogens (Durandy et al., 2013).Cell R
This is an open access article under the CC BY-NThe Igh locus of mature B lymphocytes spans more than
250 kb and comprises a rearranged VDJ region and a series of
exon sets encoding the different constant (C) regions (Cm, Cg3,
Cg1, Cg2b, Cg2a, Cε, and Ca in mice), which define the Ig iso-
types. CSR occurs through a deletional recombination event
that replaces the m constant gene of the Ig heavy chain with
one of the several downstream constant regions. The reaction
is initiated in G1 by the B cell-specific enzyme activation-
induced deaminase (AID), which targets highly repetitive
stretches of DNA preceding each constant region (switch [S] re-
gions) in a transcription-dependent manner (Chaudhuri et al.,
2003; Dickerson et al., 2003; Muramatsu et al., 2000; Ramiro
et al., 2003; Revy et al., 2000). AID activity ultimately leads to
the formation of DNA double-strand breaks (DSBs) (Boboila
et al., 2012; Methot and Di Noia, 2017). During CSR, breaks at
the donor Sm region and one of the downstream acceptor switch
regions are repaired by components of the non-homologous end
joining (NHEJ) DSB repair pathway. NHEJ directly ligates CSR
DSBs after minimal DNA end processing, resulting in deletion
of the intervening sequence and expression of the newly
switched heavy chain (Casellas et al., 1998; Chapman et al.,
2013; Di Virgilio et al., 2013; Escribano-Dı´az et al., 2013; Manis
et al., 1998, 2004; Pan-Hammarstro¨m et al., 2005; Reina-San-
Martin et al., 2003; Ward et al., 2004; Yan et al., 2007).
Productive joining of distal breaks in donor and acceptor
switch regions represents only one of the possible outcomes
of AID-induced DSB repair. Switch region breaks can also be
internally re-joined, leading to unproductive intra-switch recom-
bination (Alt et al., 1982; Bottaro et al., 1998; Dudley et al., 2002;
Gu et al., 1993; Hummel et al., 1987; Reina-San-Martin et al.,
2003, 2004; Winter et al., 1987). Given the repetitive nature of
the switch regions, intra-S recombination events are favored
by limited resection, which, combined with the intra-S break
proxymity, skews repair toward the preferential use of the
exposed microhomologies (microhomology-mediated end
joining [MMEJ]) (Boboila et al., 2010; Bothmer et al., 2013; Dun-
nick et al., 1993; Yan et al., 2007; Yancopoulos et al., 1986).
The balance between NHEJ-mediated CSR and MMEJ-in-
tra-S recombination is controlled by the DNA end resection
inhibitory function of 53BP1 (Bothmer et al., 2010, 2011, 2013;
Manis et al., 2004; Reina-San-Martin et al., 2007; Ward et al.,eports 28, 1389–1399, August 6, 2019 ª 2019 The Author(s). 1389
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Disruption of 53BP1 Higher Order Oligomerization Abrogates CSR without Affecting DSB End Protection
(A) Schematic representation of 53BP1 protein domains and OD mutants. LC8, LC8 (8 kDa light chain dynein)-binding motif; OD, oligomerization domain; Tudor,
Tudor domain; UDR, ubiquitylation-dependent recruitment motif; DBRCT, BRCA1 C terminus domains-truncated.
(legend continued on next page)
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2004), a DSB repair protein that has emerged as a key regulator
of DNA end processing (Panier and Boulton, 2014; Zimmermann
and de Lange, 2014). 53BP1 binds damaged chromatin and re-
cruits its phospho-dependent interactor Rif1, which protects
DSB ends against processing by the DNA resection-promoting
factor CtIP (Chapman et al., 2013; Di Virgilio et al., 2013; Escri-
bano-Dı´az et al., 2013; Feng et al., 2013; Zimmermann et al.,
2013). This function is mediated by the downstream REV7-
SHLD1-SHLD2-SHLD3 (shieldin) and CTC1-STN1-TEN1 (CST)
complexes, which localize to sites of DNA damage and coun-
teract DSB end resection (Dev et al., 2018; Findlay et al., 2018;
Ghezraoui et al., 2018; Gupta et al., 2018; Mirman et al., 2018;
Noordermeer et al., 2018; Tomida et al., 2018). In addition to
CSR, the DNA end resection inhibitory function of 53BP1-RIF1-
shieldin promotes fusion of telomeres that lack shelterin protec-
tion, and end joining of unrepaired chromatid breaks into radial
chromosomes in Brca1-deficient cells (Bunting et al., 2010;
Chapman et al., 2013; Dev et al., 2018; Dimitrova et al., 2008;
Ghezraoui et al., 2018; Gupta et al., 2018; Mirman et al., 2018;
Sfeir and de Lange, 2012; Zimmermann et al., 2013). These aber-
rant DNA repair reactions require 53BP1-dependent DSB end
mobility in addition to its DNA end protection function (Dimitrova
et al., 2008; Lottersberger et al., 2015).
Protection of AID-induced DSBs against resection is thought
to play a central role during CSR. However, the actual extent
to which 53BP1-Rif1-dependent repression of DNA resection
is required for CSR is not known. Here, we dissected the contri-
bution of the different functions of 53BP1 to CSR. We show that
CSR is only marginally dependent on 53BP1-Rif1-mediated inhi-
bition of DNA end processing, whereas the formation of higher
order 53BP1 oligomers is crucial for the reaction. Furthermore,
CSR does not require the DSB-induced chromatin mobility func-
tion of 53BP1. This sets CSR apart from the other DNA repair re-
actions mediated by 53BP1, fusion of deprotected telomeres
and formation of radial chromosomes.(B) Gel filtration coupled to right-angle light scattering (RALS) analysis of the OD co
brown and refers to the left y axis, whereas themolecular mass of the constructs a
the right y axis. Results are representative of two independent experiments. See
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(D) Top: representative flow cytometry plots measuring CSR to IgG1 inWT and 53
plots refer to the percentage of switched cells (IgG1+ cells). Bottom: summary dot
were normalized to the CSR value of 53BP1WT-reconstituted cells, which was se
(E) Representative WB analysis of 53bp1/ B lymphocytes reconstituted with th
(F and G) Automated IRIF quantification of immunofluorescent staining for 53BP
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(J) Summary graph showing quantification of the BrdU FACS data represented in
cell lines. Numbers above each bar indicate the fold mean BrdU intensity over W
Significance in (D), (F), (G), and (J) was calculated using the Mann-Whitney U t
****p% 0.0001; ns, not significant. See also Figure S3.RESULTS
Disruption of 53BP1 Higher Order Oligomerization
Abrogates CSR
Deletion of amino acids 1231–1270 of human 53BP1 interferes
with 53BP1 oligomerization and abrogates its ability to rescue
CSR in 53BP1-deficient B lymphocytes (Bothmer et al., 2011;
Ward et al., 2006; Zgheib et al., 2009). This amino acid stretch
contains predicted secondary structure elements (Figures 1A
and S1A), suggesting the presence of a folded oligomerization
domain (OD) in this region. To dissect how 53BP1 multimeriza-
tion supports CSR, we fused the peptide sequence encompass-
ing amino acids 1233–1288 to themaltose-binding protein (MBP)
(Figures S1B and S1C) and assessed the oligomerization status
of the fusion protein by gel filtration analysis coupled to right-
angle light scattering (RALS). In these experiments, MBP-OD
eluted as a tetramer (Figure 1B; MBP-ODWT). Mutation of the
evolutionarily conserved residue D1256 led to a dimeric species,
whereas the deletion of the OD core (amino acids 1254–1258)
rendered the protein monomeric (Figure 1B). In agreement with
these data, co-immunoprecipitation analysis of differentially
tagged 53BP1 constructs showed that deletion of the OD core
destabilized 53BP1 oligomerization more severely than the
D1256A mutation (Figure 1C). These findings indicate that the
OD acts as an independent tetramerization module, and D1256
is part of an interface that mediates dimerization of 53BP1 di-
mers. Notably, this analysis provided us with a tool to dissect
the role of 53BP1 dimerization and tetramerization for CSR and
the regulation of DNA end resection.
To assess how the differential assembly of 53BP1 influenced
its ability to support CSR, we compared the capability of
53BP1DOligo, 53BP1DCore, and 53BP1D1256A to rescue CSR in
53bp1/ B cells. We used primary cultures of splenocytes
and monitored CSR ex vivo to IgG1 in response to stimulation
with LPS and IL-4. As expected, 53bp1/ B cells exhibitednstructs fused to N-terminal MBP. UV absorbance is shown in red-blue-green-
s deduced by RALS is shown in the corresponding brighter colors and refers to
also Figure S1.
0 Gy; 1 h recovery time) BOSC23 cells transfected with the indicated 53BP1-
tification of oligomutant versus WT 53BP1-3xFlag proteins in anti-HA immu-
pendent experiments. EV, empty vector.
bp1/ splenocytes transduced with the indicated constructs. Numbers in the
plot for four independent experiments. CSR efficiencies within each experiment
t to 100%.
e indicated 53BP1 viral constructs.
1 (F) and Rif1 (G) in irradiated (10 Gy; 2 h recovery time) 53bp1/ iMEFs re-
s a representative experiment, and the bottom graph summarizes the mean
cell lines. Each symbol in the top graph represents a single cell, and the number
or or 53BP1mUDR was included in parallel to EV as an additional control in the
sed 53BP1mTudor. See also Figure S2B for representative immunofluorescent
ed cells were analyzed for BrdU content under native (not denatured) conditions
2016).
ng levels of resection in NCS-treated 53bp1/ iMEF reconstituted with the
(I) for four experiments performed on three independent sets of reconstituted
T, which was set to 1.
est, and error bars represent SD. *p % 0.05, **p % 0.01, ***p % 0.001, and
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10-fold lower levels of CSR compared with wild-type (WT) cells,
and reconstitution with 53BP1WT efficiently rescued CSR (Fig-
ures 1D and 1E). On the contrary, none of the ODmutants signif-
icantly elevated CSR efficiency above the levels of the empty
vector (EV) control or of a 53BP1 mutant that cannot associate
with chromatin (53BP1mTudor) (Figure 1D). We concluded that
the integrity of 53BP1 higher order oligomers is a pre-requisite
for CSR.
Oligomerization-Impaired 53BP1 Is Able to Counteract
DSB End Resection
In undamaged cells, 53BP1 associates with its direct binding
partner Tudor interacting repair regulator (TIRR), which binds
to 53BP1 tandemTudor domain andmasks the H4K20me2 bind-
ing surface (Botuyan et al., 2018; Dai et al., 2018; Drane´ et al.,
2017; Wang et al., 2018; Zhang et al., 2017). Upon DNA damage,
the 53BP1-TIRR complex dissociates (Drane´ et al., 2017; Zhang
et al., 2017), and 53BP1 is recruited to the damaged chromatin
via the direct bivalent interaction of its Tudor domain and ubiqui-
tination-dependent recruitment (UDR) motif with H4K20me2 and
H2AK15ub histone modifications, respectively (Botuyan et al.,
2006; Fradet-Turcotte et al., 2013; Huyen et al., 2004; Sanders
et al., 2004). 53BP1 engages the modified nucleosomes as a
dimer in a pincer-like bindingmode, and this interaction arrange-
ment has been postulated to enable its DNA end resection inhib-
itory activity (Fradet-Turcotte et al., 2013; Wilson et al., 2016).
To assess to what extent impaired oligomerization of 53BP1
affects DNA end protection against resection, we first examined
the ability of 53BP1 ODmutants to recruit Rif1 to sites of ionizing
radiation (IR)-induced DNA damage. To this end, we reconsti-
tuted 53bp1/ immortalized mouse embryonic fibroblasts
(iMEFs) with 53BP1WT and OD mutant constructs (Figure S2A)
andmonitored 53BP1 and Rif1 irradiation-induced foci (IRIF) for-
mation by high-throughput microscopy quantification. As ex-
pected, the constitutive association of 53BP1 with chromatin
(53BP1mTudor) and its DNA damage-induced recruitment
(53BP1mUDR) were necessary for efficient 53BP1 IRIF formation
(Figures 1F and S2B). In contrast, mutations or deletions disrupt-
ing the OD assembly or deletion of the entire OD only partially
affected 53BP1 localization to DSBs (Figures 1F and S2B).
Furthermore, the OD mutants were either as proficient as
53BP1WT (53BP1D1256A) or only minimally affected (53BP1DOligo
and 53BP1DCore) in recruiting Rif1 to damaged chromatin (Fig-
ures 1G and S2B). This indicates that the reduced capability of
53BP1 to localize to sites of DNA damage does not significantly
interfere with its ability to recruit Rif1.
Next, we tested the capability of these mutants to repress
resection of DNA breaks induced by the radiomimetic drug neo-
carzinostatin (NCS). To this end, we used the 5-bromo-20-deox-
yuridine (BrdU) DNA end resection assay, which measures the
levels of BrdU exposed by DNA processing as a quantitative
readout for DNA end resection (Figure 1H). In agreement with
the well-established role of 53BP1 in the inhibition of DNA end
resection, cells transduced with EVor the 53BP1mTudor mutant
displayed a high BrdU signal (Figures 1I and 1J), which is indic-
ative of extensive DNA processing. Reconstitution with 53BP1WT
rescued the phenotype (Figures 1I and 1J). OD mutant-express-
ing iMEFs exhibited only slightly increased BrdU levels1392 Cell Reports 28, 1389–1399, August 6, 2019compared with 53BP1WT (Figures 1I and 1J), indicating that
assembly via the OD does not have a major impact on 53BP1-
mediated inhibition of DNA end processing.
To assess for DNA end resection at the single nucleotide level,
we used CRISPR/Cas9 nuclease and AID as DNA break-
inducing source in CH12 cells. CH12 is amurine B cell lymphoma
line that expresses AID and undergoes efficient CSR to IgA
following cytokine stimulation (Nakamura et al., 1996). We
used CRISPR-Cas9 somatic gene targeting to generate a
CH12 cell line that harbored a deletion in the 53bp1 locus en-
compassing the OD core (53bp1D6 CH12) (Figures S3A and
S3B). This cell line recapitulated the severe CSR deficiency (Fig-
ureS3C) of oligomutant-reconstituted primaryBcells (Figure 1D).
We first monitored processing of Cas9-induced breaks at the
Rosa26 locus using a well-established DSB end resection assay
(Rosa26-ERA; Figure S3D). 53bp1D6 CH12 cells were as profi-
cient as WT cells in preventing resection of CRISPR-Cas9-
induced DSBs (Figure S3D). Next, we compared the frequency
and length of microhomologies (MHs) at Sm-Sa junctions in cells
activated to undergo CSR. 53BP1 deficiency results in CSR
junctions skewed toward the preferential use of MHs as a conse-
quence of increased resection of AID-induced breaks (Panchak-
shari et al., 2018). In agreement with this observation, 53bp1/
CH12 cells displayed the expected bias toward MH-dependent
end joining, with twice as many junctions as in WT cells present-
ingR3 bp MH (Figure S3E; Table S1). In contrast, Sm-Sa ligation
events withR3 bpMHwere only modestly increased in 53bp1D6
cells (Figure S3E; Table S1). In line with these results, 53bp1D6
CH12 cells accumulated reduced levels of the single-stranded
binding protein complex RPA at donor and acceptor switch re-
gions compared with 53bp1/ CH12 (Figure S3F).
Altogether, these findings indicate that the assembly of 53BP1
higher order oligomers via the OD is largely dispensable for inhi-
bition of DSB resection yet essential for CSR.
DSB End Protection-Deficient B Lymphocytes Undergo
Robust CSR
Following the generation of AID-induced breaks, 53BP1 recruits
Rif1 to protect switch region breaks against resection (Chapman
et al., 2013; Di Virgilio et al., 2013; Escribano-Dı´az et al., 2013).
Given the severe defect of the OD core mutants to support
CSR despite minimally affected DNA end protection capabilities,
we next examined to what extent the regulation of DNA end
resection contributed to 53BP1’s role in CSR.
53BP1’s ability to inhibit DNA end resection is dependent on
phosphorylation of the N-terminal SQ/TQ sites, as a mutant
bearing alanine substitutions of all 28 N-terminal motifs
(53BP128A; Figure 2A) cannot interact with Rif1 and support
CSR despite being normally recruited to sites of DNA damage
(Bothmer et al., 2011; Chapman et al., 2013; Di Virgilio et al.,
2013; Escribano-Dı´az et al., 2013). However, 53BP128A is also
impaired in DNA damage-induced chromatin mobility, a Rif1-in-
dependent function of 53BP1 that is required for both telomere
fusion and radial formation (Dimitrova et al., 2008; Lottersberger
et al., 2013, 2015; Zimmermann et al., 2013). To assess the spe-
cific contribution of Rif1-mediated inhibition of DSB resection to
CSR, we generated 53BP1 mutants that harbored alanine sub-
stitutions in the SQ/TQ sites within the N-terminal DNA end
AB C
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Figure 2. Inactivation of 53BP1 SQ/TQ Sites T302 to S625 Is Sufficient to Abolish Rif1-Dependent Inhibition of DNA End Resection
(A) Top: schematic representation of 53BP1 protein with the position of the 28 N-terminal SQ/TQ motifs indicated as black circles. Bottom: schematic repre-
sentation of the 53BP1 phospho mutants with S/TQ sites indicated as black circles and S/TQ-to-AQ substitutions marked in light gray. Pro, DNA end protection
SQ/TQ set; Mob, DNA mobility SQ/TQ set.
(B and C) Automated IRIF quantification of immunofluorescent staining for 53BP1 (B) and Rif1 (C) in irradiated (10 Gy; 2 h recovery time) 53bp1/ iMEFs re-
constituted with the indicated constructs. The top graph within each panel shows a representative experiment, and the bottom graph summarizes the mean
values of three experiments performed on three independent sets of reconstituted cell lines. Each symbol in the top graph represents a single cell, and the number
of scored cells wasR200 per sample. The mean is indicated. See also Figure S2D for representative immunofluorescent staining images.
(D) Representative BrdU FACS plots showing levels of resection in NCS-treated 53bp1/ iMEFs reconstituted with the indicated constructs.
(E) Summary graph showing quantification of the BrdU FACS data represented in (D) for six experiments performed on three independent sets of reconstituted
cell lines. Numbers above each bar indicate the fold mean BrdU intensity over WT, which was set to 1.
Significance in (B), (C), and (E) was calculated using theMann-Whitney U test, and error bars represent SD. **p% 0.01 and ****p% 0.0001; ns, not significant. See
also Figure S4B.
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protection domain (Pro domain; Figure 2A) but retained all
SQ/TQ sites in the mobility domain (Mob domain; Figure 2A).
This yielded 53BP1DPro, which contained mutations in the first
15 N-terminal SQ/TQ sites, and 53BP1DRif1, which preserved
the SQ sites in the PTIP-binding region (Figure 2A).
To assess whether abrogation of SQ/TQ phosphorylation in
the 53BP1DPro and 53BP1DRif1 mutants interfered with Rif1 inter-
action and recruitment to DSBs, we reconstituted 53bp1/
iMEFs with 53BP1WT and 53BP1 phospho mutants (Figure S2C),
and monitored 53BP1 and Rif1 foci formation after irradiation. In
agreement with the observation that N-terminal phosphorylation
is dispensable for recruitment of 53BP1 to sites of DNA damage,
53BP128A (Bothmer et al., 2011), 53BP1DPro and 53BP1DRif1 foci
were readily detectable following irradiation (Figures 2B and
S2D). However, Rif1 did not form IRIF in 53BP1DPro and
53BP1DRif1-reconstituted cells (Figures 2C and S2D), thus
indicating that both phospho mutants cannot support Rif1 reloc-
alization to DSBs.
We next tested whether the inability of 53BP1DPro and
53BP1DRif1 to recruit Rif1 to sites of DNA damage translated
into impaired DNA end resection inhibition. iMEFs reconstituted
with Rif1 interaction-deficient 53BP1 mutants displayed the
same increased levels of resection as cells lacking 53BP1 (EV
transduced) or cells expressing a 53BP1 mutant defective in
DSB-induced chromatin recruitment (53BP1mUDR) (Figures 2D
and 2E). These experiments confirm that Rif1 is themajor effector
in the regulation of DNA end resection downstream 53BP1. Alto-
gether, these results indicate that abrogation of phosphorylation
at SQ/TQ sites T302 to S625 is sufficient to abolish Rif1 recruit-
ment to DSBs and 53BP1-dependent DNA end protection.
To assess to what extent 53BP1-Rif1-mediated regulation of
DNA end processing contributes to CSR, we reconstituted
53bp1/ splenocytes with 53BP1DPro and 53BP1DRif1 (Figures
3A–3C). Phosphomutant-expressing splenocyte cultures dis-
played the same proliferation capability as their WT counterpart
(Figure S4A). We first assessed 53BP1DPro and 53BP1DRif1 profi-
ciency to interact with Rif1 following DNA damage by co-immu-
noprecipitation analysis. In agreement with the inability to recruit
Rif1 to IR-induced DSBs in MEFs (Figures 2C and S2D),
53BP1DPro and 53BP1DRif1 failed to co-immunoprecipitate Rif1
following IR in B cells (Figure S4B). Next, we assessed CSR effi-
ciency ex vivo in response to stimulation conditions that induce
class switching to different isotypes. We monitored switching
to IgG1, IgG2b, and IgG3 because CSR to these isotypes is
robust, and thus it ensures a large dynamic range and amore ac-
curate detection of even subtle differences in CSR levels.
Whereas CSR was abrogated to all tested isotypes in
53bp1/ B cells transduced with EV or 53BP1mUDR, Rif1 inter-
action-deficient 53BP1 rescued CSR to a considerable extent
under all stimulation conditions (Figures 3D–3F; mean values of
72%, 66%, and 65% of WT levels for IgG1, IgG2b, and IgG3,
respectively, for 53BP1DRif1). Taken together, these results indi-
cate that 53BP1-Rif1 DSB end protection plays a limited role in
53BP1’s ability to support CSR.
53BP1-Dependent DSB Mobility Is Dispensable for CSR
53BP1 mediates the mobility of deprotected telomeres and
DSBs (Dimitrova et al., 2008; Lottersberger et al., 2015). This1394 Cell Reports 28, 1389–1399, August 6, 2019function contributes to telomere fusion following ablation of the
shelterin component TRF2, and generation of radial chromo-
somes in BRCA1-deficient cells (Dimitrova et al., 2008; Lotters-
berger et al., 2015), the other two well-established DNA repair
transactions that depend on 53BP1. Alanine substitutions of an
internal set of SQ/TQ motifs (53BP1DMob; Figure 2A) abrogate
53BP1-dependent DNA end mobility without affecting its ability
to repress hyper-resection of deprotected telomeres (Lotters-
berger et al., 2015). In agreement with these data, 53BP1DMob
rescued Rif1 foci formation in irradiated 53bp1/ iMEFs to WT
levels (Figures 2C and S2D) and was proficient in protecting
DSBs against resection (Figures 2D and 2E).
Given the limited dependency of CSR on 53BP1 regulation of
DNA end processing, we tested whether 53BP1-mediated DSB
mobility contributed to CSR. To do so, wemeasured the CSR ef-
ficiency of 53bp1/ splenocytes reconstituted with 53BP1DMob
mutant. 53BP1DMob rescued CSR to WT levels (Figures 4A and
4B), thus indicating that inactivation of DNAmobility SQ/TQ sites
did not affect 53BP1’s ability to support CSR.We concluded that
53BP1-mediated DSB end mobility is dispensable for CSR. In
this regard, CSR differs from the other DNA repair transactions
that are dependent on 53BP1, fusion of deprotected telomeres
and radial formation, which both require the DNA end mobility
activity in addition to the inhibition of DNA end resection
(Figure 4C).
DISCUSSION
Whereas CSR is predominantly dependent on NHEJ, the repet-
itive nature of the switch regions favors MMEJ-mediated
intra-S recombination, and the ability of 53BP1-Rif1 to coun-
teract DNA end processing is believed to contribute substan-
tially to the severe CSR defects caused by deficiency in these
DSB repair factors. Here, we showed that B lymphocytes
devoid of 53BP1-Rif1-mediated DNA end protection can
undergo robust class switching. Conversely, defects in higher
order multimerization completely abolish 53BP1’s ability to
support CSR without having a major impact on its DNA end
resection inhibitory function. Considering the near complete
abrogation of CSR in 53BP1- and Rif1-deficient B cells
(Chapman et al., 2013; Di Virgilio et al., 2013; Escribano-Dı´az
et al., 2013; Manis et al., 2004; Ward et al., 2004), the major
implication of these findings is that 53BP1 and Rif1 contribute
multiple functions to CSR, with the regulation of DNA end
resection activity only marginally influencing the process. This
would explain the surprising observation that inhibition of
CtIP-mediated end resection only negligibly rescues the CSR
defect in 53BP1 and Rif1-deficient B lymphocytes (Bothmer
et al., 2013; Di Virgilio et al., 2013).
Despite a partially defective association with damaged
chromatin, 53BP1 OD mutants supported considerable Rif1
recruitment and inhibition of DNA end resection. These results
are reminiscent of the behavior of OD-impaired 53BP1 at
dysfunctional telomeres (Lottersberger et al., 2013). 53BP1DOligo
exhibited only a mild localization defect to deprotected telo-
mere-induced foci (TIFs) but was fully proficient with regard to
counteracting CtIP-mediated telomere resection (Lottersberger
et al., 2013). These observations raise the possibility that an
A B C
D E F
Figure 3. DSB End Protection-Deficient B Lymphocytes Undergo Robust CSR
(A–C) Representative WB analysis of 53bp1/ B lymphocytes reconstituted with the indicated 53BP1 viral constructs and stimulated to induce CSR to IgG1 (A),
IgG2b (B), or IgG3 (C). Asterisk indicates an aspecific band used for internal normalization of protein levels. Numbers underneath each lane indicate mean values
from relative quantification of 53BP1WT and mutant protein levels in reconstituted 53bp1/ splenocytes cultures compared with endogenous protein in theWT
B cell culture. Quantification summarizes WB analyses of three independently reconstituted cultures per stimulation condition.
(D–F) Top: representative flow cytometry plots measuring CSR to IgG1 (D), IgG2b (E), and IgG3 (F) in primary cultures of 53BP1 construct-reconstituted 53bp1/
B lymphocytes. Bottom: summary dot plot for three independent experiments. CSR efficiencies within each experiment were normalized to the CSR value of
53BP1WT-reconstituted cells, which was set to 100%.
Significance was calculated using the Mann-Whitney U test, and error bars represent SD. *p% 0.05 and **p% 0.01.independent oligomerization module may compensate for
mutations within the OD and support sufficient levels of 53BP1
recruitment to damaged sites to ensure repression of DNA end
processing (DSBs or dysfunctional telomeres). Indeed, during
the preparation of this paper, another study reported that binding
of the dimerization-inducing protein DYNLL1 to the LC8 motif in
53BP1 promoted OD-independent oligomerization and chro-matin association (Becker et al., 2018). Given the milder chro-
matin recruitment defect of the 53BP1 LC8 mutant (Becker
et al., 2018), the OD is likely to play a key role in the stabilization
of 53BP1 oligomers.
We have found that the OD provides a tetramerization inter-
face, and efficient higher order 53BP1 multimerization is essen-
tial for CSR. A single mutation within the OD core that stillCell Reports 28, 1389–1399, August 6, 2019 1395
AB
C Figure 4. 53BP1-Mediated DSB Mobility Is
Dispensable for CSR
(A) Top: representative flow cytometry plots
measuring CSR to IgG1 in WT and 53bp1/ sple-
nocytes transduced with the indicated constructs.
Bottom: summary dot plot for four independent ex-
periments. CSR efficiencies within each experiment
were normalized to the CSR value of 53BP1WT-re-
constituted cells, which was set to 100%. Signifi-
cance was calculated using the Mann-Whitney
U test, and error bars represent SD. *p % 0.05; ns,
not significant.
(B) Representative WB analysis of 53bp1/ B lym-
phocytes reconstituted with the indicated 53BP1
viral constructs.
(C) Schematic representation of a 53BP1 tetramer.
The blue appendages represent the N-terminal
intrinsically disordered regions of eachmonomer and
contain the Pro and Mob sets of SQ/TQ motifs. The UDR and Tudor domains of the 53BP1 monomers assemble into two nucleosome-binding dimers that are
represented as yellow pincers. The relative contributions played by the regulation of DNA end processing, DSB mobility, and higher order oligomerization
activities to CSR are indicated in red.supports dimerization of theODmodule abolishes CSR. Interest-
ingly, deletion of the OD had a minor effect on the end joining of
deprotected telomeres that specifically concerned the longest
multichromosome fusion events, which might be limited by a
less efficient interaction of distally located telomeric ends (Lot-
tersberger et al., 2013). These findings are in agreement with a
model in which 53BP1 dimers represent the minimum nucleo-
some-binding unit to allow DNA damage-dependent recruitment
and inhibition of DNA end resection, whereas tetramerization
(and higher order assembly) provides a tethering activity to
bridge and stabilize distally located DNA ends (Figure 4C),
including AID-induced DSBs in donor and acceptor switch re-
gions or spatially separated telomeric ends. Consistent with
this idea, 53BP1 facilitates long-range DNA end joining during
V(D)J recombination (Difilippantonio et al., 2008). The combined
contribution of DSB end protection and distal break tethering to
CSR explains the increase in MMEJ-mediated intra-S region
repair events in 53BP1-deficient B cells (Reina-San-Martin
et al., 2007).
CSR is a complex process that relies on the coordinated inter-
play of chromatin reorganization, transcription, programmed
DNA damage, and DSB repair (Chaudhuri and Alt, 2004; Methot
and Di Noia, 2017; Yewdell and Chaudhuri, 2017). It is not at all
surprising that specific factors could contribute multiple func-
tions within the same or even different steps of the reaction.
Indeed, additional Igh locus-specific functions have been
described for 53BP1, including enforcement of orientation-spe-
cific joining of AID breaks and a structural role in the mainte-
nance of the locus architecture (Dong et al., 2015; Feldman
et al., 2017; Rocha et al., 2016). The extent to which these func-
tions contribute to CSR is currently unknown. However, these
and our findings suggest that, in addition to preventing resection
of AID-induced breaks via Rif1 and the shieldin complex, 53BP1
plays the key role of maintaining the Igh locus in a configuration
‘‘primed’’ for productive CSR events.
No additional role during CSR has been described for Rif1 so
far. However, we recently performed a proteomic-based screen
to identify Rif1 interactors in primary B lymphocytes undergoing1396 Cell Reports 28, 1389–1399, August 6, 2019CSR and identified several transcriptional regulators in addition
to genome stability factors (Delgado-Benito et al., 2018). This rai-
ses the intriguing possibility that Rif1might contribute to the tran-
scriptional control of CSR. Such a hypothesis is in line with
several studies supporting Rif1 role as a transcriptional regulator
in yeast and mammals (Dan et al., 2014; Daxinger et al., 2013;
Hardy et al., 1992; Kim et al., 2008; Li et al., 2017; Loh et al.,
2006; Smith et al., 1999; Tanaka et al., 2016; Wang et al.,
2006) and represents an exciting new direction of investigation
into the coordinated control of pre- and post-DSB phases
of CSR.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Sources of mouse models and cell lines used in the study are reported below and in the Key Resources Table.
Mice strains
53bp1/mice (B6;129-Trp53bp1tm1Jc/J) were previously described (Ward et al., 2003). 6 to 20 weeks old animals were used for the
study, and age-matched groups were employed within each experiment. Both male and female mice were used for the experiments.
Mice weremaintained in a specific pathogen-free (SPF) barrier facility under standardized conditions (20+/2C temperature; 55% ±
15% humidity) on a 12 h light/12 h dark cycle. All experiments were performed in compliance with EU Directive 2010/63/EU, and in
agreement with protocols approved by Landesamt f€ur Gesundheit und Soziales (LAGeSo, Berlin).
Primary cell cultures
Splenocytes cultures from 53bp1/ mice were grown in RPMI 1640 medium (Life Technologies) supplemented with 10% fetal
bovine serum (FBS), 10 mM HEPES (Life Technologies), 1 mM Sodium Pyruvate (Life Technologies), 1X Antibiotic Antimycotic
(Life Technologies), 2 mM L-Glutamine (Life Technologies), and 1X 2-Mercaptoethanol (Life Technologies) at 37C and 5% CO2
levels.
Cell lines
The cell lines employed for this study are: CH12 (CH12F3, murine, (Nakamura et al., 1996)), 53bp1/ (Trp53bp1/) CH12 (murine,
(Delgado-Benito et al., 2018)), 53bp1D6 CH12 (murine, this paper), WT and 53bp1/ iMEFs (murine, (Bothmer et al., 2011)), and
BOSC23 (human, (Pear et al., 1993)). CH12 cells were grown in RPMI 1640 medium supplemented with 10% fetal bovine serum
(FBS), 10 mM HEPES, 1 mM Sodium Pyruvate, 1X Antibiotic Antimycotic, 2 mM L-Glutamine, and 1X 2-Mercaptoethanol at 37C
and 5% CO2 levels. iMEFs and BOSC23 cells were cultured in DMEM medium (Life Technologies) supplemented with 10% FBS,
2 mM L-Glutamine, and Penicillin-Streptomycin (Life Technologies) at 37C and 5% CO2 levels.
METHOD DETAILS
Protein expression
The nucleotide-sequence encoding residues 1233-1288 of human 53BP1 (Uniprot Q12888) was amplified by PCR and cloned into a
modified pET21b+ vector (Novagen #69741) encoding N-terminal MBP, followed by a 24 amino acid long linker. Site-directed muta-
genesis was used to introduce the indicated mutations. The plasmids were transformed into E.coli BL21 Rosetta 2 (Novagen) and
cells were grown at 37C in ExpressTM medium (Novagen) until an optical density at a wavelength of 600 nm (OD600) of 0.9, when
the temperature was switched to 18C for overnight expression. Alternatively, protein was produced in LB medium by inducing pro-
tein expression at an OD600 of 0.4 with 1 mM IPTG and 4 h incubation at 37
C. Cells were harvested by centrifugation and cell pellets
stored at20C until purification. Thawed cells were resuspended in 20mMHEPES (or 20mMTris-HCl) pH 7.5, 150mMNaCl, 1 mMe3 Cell Reports 28, 1389–1399.e1–e6, August 6, 2019
DTTwith AEBSF (4-(2-Aminoethyl)benzensulfonylfluorid) and cOmpleteTM protease inhibitor (Roche) and lysedwith a fluidizer (Micro-
fluidics). Cell lysates were centrifuged at 35,000 rpm for 45 min at 4C. The filtered supernatant was then incubated with 25 U/ml
Benzonase for 25min at 4C to reduce nucleic acid contaminations and subsequently applied to an equilibratedMBP affinity column
(GE). The column was washed with 20 column volumes (CV) of resuspension buffer at 4C. Protein was eluted with 10 CVs of 20 mM
HEPES (or 20 mM Tris-HCl) pH 7.5, 150 mM NaCl, 1 mM DTT, 40 mM maltose. The eluted protein was concentrated to 20 mg/ml
using 10 kDa cutoff Amicon spin filters, followed by size exclusion chromatography on a Superdex S200 in running buffer containing
20 mM HEPES (or 20 mM Tris-HCl) pH 7.5, 150 mM NaCl, 1 mM DTT. Pooled fractions were concentrated in 10 kDa cutoff Amicon
spin filters and frozen in small aliquots. Protein size was verified using MALDI-TOF with a 4-point calibration standard and sinapinic
acid or a-cyano-4-hydroxycinnamic acid as matrix.
RALS analysis
RALS analysis was performed on an analytical Superdex S200 10/300 column in running buffer containing 20 mM HEPES pH 7.5,
150 mM NaCl, 1 mM DTT, using an A¨KTApurifier and an online Malvern Viscotek RALS system (VE 3580 RI detector and 270
Dual detector). All protein samples were diluted to 2 mg/ml concentration in running buffer. 50 ml of each sample was applied and
run at a flowrate of 0.5 ml/min. Data was recorded with UNICORN and OmniSEC 5.00 software and analyzed in OmniSEC 5.00 soft-
ware. MBP expressed from plasmid pMAL-C2X was used as a control. Molecular weight (MW) of MBP-OD: 49.5 kDa. The clear shift
in the elution volume of MBP (MW: 42.5 kDa) and MBP-ODDCore (MW: 48.6 kDa) in Figure 1B is likely caused by the more extended
shape of MBP-ODDCore.
Cell cultures and retroviral infection
B lymphocytes were isolated from mouse spleens using anti-CD43 MicroBeads (Miltenyi Biotec) and stimulated to undergo class
switching with 25 mg/ml LPS (Sigma-Aldrich) and 5 ng/ml of mouse recombinant IL-4 (Sigma-Aldrich) for CSR to IgG1; 25 mg/ml
LPS, 10 ng/ml BAFF (PeproTech) and 2 ng/ml TGFb (R&D Systems) for CSR to IgG2b; or 25 mg/ml LPS for CSR to IgG3. Cultures
were supplemented with 0.5 mg/ml RP105 (BD) under all stimulation conditions. CH12 cells (Nakamura et al., 1996) were stimulated
to undergo CSR to IgA by treatment with 0.5 mg/ml aCD40 (BioLegend), 5 ng/ml TGFb and 5 ng/ml of mouse recombinant IL-4
for 48 h.
pMX-53BP1 retroviral vectors were generated by cloning the cDNA for human 53BP1DBRCT (aa 1-1710) into a pMX-based vector
with a C-terminal 3XFlag tag. 53BP1DBRCT backbone was employed as WT and for mutagenesis purposes since its reduced size
allows efficient retroviral packaging and infection of B cells, while functionally behaving as the full-length protein in CSR, radials for-
mation, and fusion of deprotected telomeres (Bothmer et al., 2011; Lottersberger et al., 2013). The 53BP1 mutants employed in this
study are: 53BP1DOligo (D1231-1270, (Ward et al., 2006)), 53BP1DCore (D1254-1258, this study), 53BP1D1256A (Zgheib et al., 2009),
53BP1mTudor (D1521R, (Botuyan et al., 2006)), 53BP128A (S6A, S13A, S25A, S29A, S105A, S166A, S176A, S178A, T302A, S437A,
S452A, S523A, T543A, S580A, S625A, S674A, T696A, S698A, S784A, S831A, T855A, S892A, S1068A, S1086A, S1104A, S1148A,
T1171A, S1219A, (Bothmer et al., 2011)), 53BP1DPro (S6A, S13A, S25A, S29A, S105A, S166A, S176A, S178A, T302A, S437A,
S452A, S523A, T543A, S580A, S625A, this study), 53BP1DRif1 (T302A, S437A, S452A, S523A, T543A, S580A, S625A, this study),
53BP1DMob (S674A, T696A, S698A, S784A, S831A, T855A, S892A, S1068A, S1086A, S1104A, S1148A, T1171A, S1219A, (Lotters-
berger et al., 2015)), and 53BP1mUDR (L1619A, (Fradet-Turcotte et al., 2013)). 53BP1DPro was generated by combining the sequence
containing the first 15 mutated SQ/TQ to SA/TA sites from 53BP128A and the sequence containing the following 13 SQ/TQ sites from
53BP1WT into pMX vector using a new SgrAI site introduced via silent mutations at nucleotides 1893 and1896 of human 53BP1 cod-
ing sequence. 53BP1DMob was generated by combining the sequence containing the first 15 SQ/TQ sites from 53BP1WT and the
sequence containing the following 13 mutated SQ/TQ to SA/TA sites from 53BP128A into pMX vector using the same strategy
employed for 53BP1DPro. Primers used for 53BP1DPro/53BP1DMob cloning are listed in Table S2. 53BP1DRif1 was generated by
subcloning the sequence encompassing the first 8 SQ sites from pMX-53BP1WT into pMX-53BP1DPro using BsrGI cloning site. 3x
haemagglutinin (3xHA) tag was cloned at the C terminus of 53BP1DBRCT by two sequential PCR rounds using the primers listed in
Table S2.
Splenocytes infections were performed as it follows. The 293T derivative cell line BOSC23 (Pear et al., 1993) was transfected with
pCL-Eco and pMX-53BP1 retroviral vectors using FuGENE HD Transfection Reagent (Promega) to generate viral particle-contain-
ing supernatants. B cells were transduced twice with the viral supernatant, one and two days after isolation, and CSR was assessed
96 h post-activation. To control for any difference in the expression of the transduced constructs within each reconstitution exper-
iment, 53BP1 protein levels were routinely monitored by western blot analysis, as it has been previously described (Bothmer et al.,
2011; Callen et al., 2013; Di Virgilio et al., 2013; Fradet-Turcotte et al., 2013). iMEFs were transduced as described for splenocytes
above, with the exception that only one round of infection was employed one day after seeding, and 2 mg/ml Puromycin (Sigma-
Aldrich) was added to the cultures 24 h after infection.
Generation of 53BP1 oligo mutant expressing CH12 cell lines
CH12 clonal derivativeswere generated via electroporation with gRNApairs and nickase Cas9-based plasmid. TandemU6 cassettes
were cloned into amutated version of pX458 expressing Cas9D10A. Single GFP-positive cells were sorted in 96-well plates and clones
were allowed to grow for 12 days before expansion. Clones were validated at the level of genomic scar and protein expression. TheCell Reports 28, 1389–1399.e1–e6, August 6, 2019 e4
sequences of the gRNAs employed in this study are listed in Table S2. Controls for 53bp1/ and 53BP1 oligo mutants-expressing
clonal derivatives included both WT cultures and clones derived from targeting CH12 with random sequences not present in mouse
genome. CH12 cell lines were activated for 48 h with aCD40, IL-4, and TGFb to induce CSR to IgA.
Western blot analysis and Co-IP assays
Western blot analysis of protein levels was performed on whole cell lysates prepared by lysis in RIPA buffer (Sigma) supplemented
with Complete EDTA free proteinase inhibitors (Roche).
For co-immunoprecipitation of differentially tagged 53BP1 proteins, BOSC23 cells were co-transfected with equal amounts of
pMX-53BP1WT-3xHA and pMX-53BP1-3xFlag (WT, DOligo, DCore, or D1256A) using FuGENE HD Transfection Reagent. 36 hours
post-transfection, cells were irradiated (20 Gy) and left to recover for 1 hour. Cells were lysed in lysis buffer (20 mM Tris HCl,
150 mM NaCl, 0.5% Igepal CA-630 (Sigma), 1.5 mM MgCl2) supplemented with Complete EDTA-free protease inhibitor cocktail,
Pepstatin A (Merck), phenylmethylsulfonyl fluoride (PMSF) (Sigma), Pierce Phosphatase Inhibitors (ThermoFisher), and Benzonase
(Sigma). Lysates were clarified by 15 min centrifugation at 13,000 rpm at 4C, and incubated with magnetic beads (DynaBeads Pro-
tein G, Thermo Fisher) conjugated with anti-HA antibody (Santa Cruz) for 1 h at 4 C. Proteins were eluted by incubation in NuPAGE
LDS sample buffer (Invitrogen) supplemented with 45 mM DTT for 10 min at 72C.
For 53BP1-Rif1 co-immunoprecipitation analysis, 53bp1/ splenocytes were activated with 25 mg/ml LPS, 5 ng/ml of mouse re-
combinant IL-4, and 0.5 mg/ml RP105, and infected with pMX-53BP1-3xFlag retroviral constructs as described above. At 96 h post-
activation, cells were irradiated (20Gy) and left to recover for 1 hour. Cells were harvested, and washed two times with 1x PBS and
one timewith polyvinylpyrrolidone (PVP) buffer (20mMHEPES, 1.2%PVP 40, Complete EDTA-free protease inhibitor cocktail, Pierce
Phosphatase Inhibitors, 0.5 mMDTT, Pepstatin A, and PMSF). Cells were lysed in lysis buffer (10 mM Tris HCl, 100 mMNaCl, 0.05%
Igepal CA-630, 1 mM MgCl2) supplemented with Complete EDTA-free protease inhibitor cocktail, Pierce Phosphatase Inhibitors,
Pepstatin A, PMSF, and Benzonase. Lysates were clarified by 15 min centrifugation at 13,000 rpm at 4C, and incubated with mag-
netic beads (DynaBeads Protein G, Thermo Fisher) conjugated with anti-Flag M2 antibody (Sigma-Aldrich) for 1 h at 4C. Proteins
were eluted by incubation in NuPAGE LDS sample buffer supplemented with 45 mM DTT for 10 min at 72C.
The antibodies used for WB analysis are: anti-53BP1 (Novus Biological), anti-Flag M2 (HRP conjugated) (Sigma-Aldrich), anti-Rif1
(Di Virgilio et al., 2013), anti-Tubulin (Abcam), and anti-HA (Cell Signaling).
The indicated MWs of 214 and 190 kDa in the anti-53BP1 blots refer to the endogenous full-length 53BP1 and the retrovirally
expressed DBRCT proteins, respectively.
Flow cytometry
For class switching assays, cell suspensions were stained with fluorochrome-conjugated anti-IgG1, anti-IgG3 (BD-Biosciences),
anti-IgG2b (BioLegend), or anti-IgA (Southern Biotech). Samples were acquired on an LSRFortessa cell analyzer (BD-Biosciences).
For cell proliferation analysis by cell tracking dye dilution, primary B cells were pulsed with 5 mM CellTrace Violet (Thermofisher) for
20 min at 37C.
Immunofluorescence
iMEFs were grown on coverslips overnight. Cells were irradiated (10 Gy IR) and allowed to recover for 2 h. Upon fixation with 4%
paraformaldehyde (Sigma-Aldrich) and permeabilization with 0.5% Triton X-100, cells were stained with mouse anti-Flag M2
(Sigma-Aldrich), and rabbit anti-Rif1 serum (Di Virgilio et al., 2013) antibodies as primary antibodies, and with goat anti-rabbit
Alexa546 and goat anti-mouse Alexa488 (Invitrogen) as secondary antibodies, alongside permeable nuclear dye (Hoechst dye
33258, ThermoFisher). Images were acquired using inverted LSM700 laser scanning confocal microscope (Zeiss) for the represen-
tative images in Figures S2B and S2D, and with inverted fluorescence phase contrast microscope Keyence BZ-X800E (Keyence) for
the automated foci quantification in Figures 1F, 1G, 2B, and 2C.
BrdU assay for DNA end resection
The BrdU assay for DNA end resection was performed as previously described (Tka´c et al., 2016). Briefly, iMEFs were incubated with
30 mM BrdU for 24 h, followed by treatment with 200 ng/mL Neocarzinostatin (NCS) for 3 h (+NCS samples) or mock-treated (-NCS
samples). Cells were trypsinized, washed with PBS, and fixed with 75% ethanol in PBS for 16 h at 20C. Cells were washed with
0.1% Tween 20 in PBS following fixation and each subsequent incubation. Each sample was split into 2 aliquots, one of which was
denatured using 2 N HCl for 45 min at 22C in order to measure total BrdU incorporation. Blocking was performed in 5% fetal bovine
serum (FBS) in PBS for 1 h at 22C. BrdU exposed on single-stranded DNA (ssDNA) stretches as a consequence of DNA end resec-
tion was detected under native conditions by incubation with APC-conjugated anti-BrdU antibody (BioLegend) in PBS supplemented
with 5% FBS for 1 h at 22C. BrdU fluorescence intensity was acquired using the BD LSRFortessa flow cytometer (BD Biosciences).
Resection levels in Figures 1J and 2E were expressed as themean BrdU intensity of native NCS-treated cells normalized to themean
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Rosa26 DNA end resection assay (Rosa26-ERA)
The end resection assay was performed as previously described (Delgado-Benito et al., 2018). Single guide RNAs targeting two se-
quences 2276 bp apart within the ROSA26 locus (gDSB-1 and gDSB-2) were cloned independently into pX458 plasmid (gDSB-1/2).
CH12 cells were electroporated with a 1:1 mix of gDSB-1 and gDSB-2 constructs using the Neon Transfection System (Thermo
Fisher Scientific). 24h later, GFP-positive cells were sorted and pellets were frozen. Genomic DNA was extracted according to stan-
dard protocols and individual repair junctions were amplified using nested PCR reactions. PCR products were extracted from
agarose gel and sequenced. Single guide RNAs and primers used for the end resection assay are listed in Table S2.
RPA-ChIP
ChIP-qPCR for RPA was performed as it follows. 20 million cells were counted and stimulated for 30 h with 0.5 mg/ml aCD40, 5 ng/ml
TGFb, and 5 ng/ml of mouse recombinant IL-4. Cells were fixed with 1% Formaldehyde (Thermo Scientific) at 37C for 10 min fol-
lowed by addition of 1/20 volume of 2.5 M glycine (dissolved in PBS pH 7.4). Fixed cells were washed two times with ice cold
PBS, centrifuged and aliquoted. Cells were resuspended in 800 mL of RIPA buffer supplemented with Complete EDTA free proteinase
inhibitor and sonication was performed with a Covaris S220 Focused Ultrasonicator (peak value 105, duty factor 5, cycle/burst 200
for 20 minutes). Each ChIP was performed using 50-60 mg of chromatin. Chromatin fragments were pre-cleaned by incubation with
Dynabeads Protein G (Thermofisher) with rotation at 4C for 1 h, and immunoprecipitated with antibody-bound Dynabeads. 10 mg
antibodies specific for RPA2 (Novus Biologicals) or normal mouse IgG (Santa Cruz) were used for each sample. DNA was amplified
using Luna Universal One-Step RT-qPCR Kit (NEB) on a StepOnePlus qPCR machine (Thermofisher). Primers used for RPA-ChIP
analysis (Wiedemann et al., 2016) are listed in Table S2.
Switch Junction Analysis
For Sm-Sa junctional analysis in CH12, cells were stimulated for 48 h with 0.5 mg/ml aCD40, 5 ng/ml TGFb and 5 ng/ml of mouse re-
combinant IL-4, and sorted for IgA+ cells. Genomic DNA was extracted from the sorted population, and Sm-Sa junctions were ampli-
fied by Expand long template PCR system (Sigma Aldrich). PCR conditions were: 38 cycles of denaturation 94C for 1500, annealing
60C for 300, and elongation 68C for 300 (plus 300 at each following cycle). PCR products were run on agarose gels, and fragments
corresponding to 350-1000 bp were extracted with NucleoSpin DNA Purification Kit (Macherey-Nagel), cloned using TOPO-TA
cloning kit (Invitrogen), and sequenced using M13 forward and reverse universal primers. Primers used for switch junction analysis
(Lee-Theilen et al., 2011) are listed in Table S2.
QUANTIFICATION AND STATISTICAL ANALYSIS
The statistical significance of differences between groups/datasets was determined by the Mann–Whitney U test for all data pre-
sented in this study. Error bars in Figures 1D, 1J, 2E, 3D–3F, 4A, and S3C represent SD. Statistical details of experiments can
also be found in the figure legends. Western blots were quantified using ImageJ image processing program (NIH). For quantification
of oligomutant versus WT 53BP1-3xFlag proteins in anti-HA immunoprecipitates in Figure 1C, the signal associated with 53BP1-
3xFlag proteins was normalized against the levels of 53BP1WT-3xHA in each corresponding pull-down. For quantification of
53BP1 protein levels in the western blot analyses in Figures 3A–3C, and repeats, the signal associated to 53BP1 was normalized
with that of a aspecific reference band present in all lanes. IR-induced foci quantification in Figures 1F, 1G, and 2B, and 2C was
performed using the BZ-H4A/Advanced Analysis Software, BZ-H4C/Hybrid Cell Count and BZ-H4CM/Macro Cell Count analysis
applications (Keyence).
DATA AND CODE AVAILABILITY
Original imaging and western blot data used to generate any of the figure panels have been deposited at Mendeley: https://data.
mendeley.com/datasets/n7jxbpddnf/draft?a=d8838dbd-c9e9-40d5-b467-0150330356a1Cell Reports 28, 1389–1399.e1–e6, August 6, 2019 e6
